Oct 24,2016

Tandem Diabetes Care Now Shipping Next-Generation t:slim X2 Insulin Pump

Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced commencement of shipments for its next-generation t:slim X2™ Insulin Pump.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Oct 25,2016

Brighter merges the jDome business with Bestic and plans a public listing as an independent company.

Via its subsidiary, Brighter Two AB, Brighter AB acquired Bestic AB, a Swedish robotics company that develops and sells products and assistive devices for the healthcare and nursing sector. In conjunction with the acquisition, Brighter Two, which develops and sells jDome® BikeAround™, is merged with Bestic AB.

COLLABORATION MERGERS & ACQUISITION

#product & service

View Analyst & Ambassador Comments
Go to original news
Oct 25,2016

DarioHealth Reports Successful Traction for Dario

DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario™ Blood Glucose Monitoring System, an all-in-one diabetes meter, today announced continued adoption for its revolutionary mobile app-based and minimally invasive smart diabetes management solution. In just six months since its U.S. launch, Dario is demonstrating positive trends in terms of meters purchased in the U.S.

PRODUCT

#mobile app

#bgm

View Analyst & Ambassador Comments
Go to original news
Oct 27,2016

Senseonics submits Eversense® Continuous Glucose Monitoring system PMA to FDA

Senseonics Holdings, Inc. (NYSE-MKT:SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it has submitted to the U.S. Food and Drug Administration (FDA) a Premarket Approval (PMA) application for its Eversense® CGM system.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Oct 28,2016

Ascensia Diabetes Care Sponsored Workshop at ISPAD 2016 Highlights Importance of Digital Technology to Support Diabetes Self-Management in Paediatrics and Adolescents

Today, at a workshop organized by Ascensia Diabetes Care, a renowned panel of experts highlighted the importance of digital technology to support diabetes self-management in paediatrics and adolescents. The workshop occurred at the 42nd Annual Meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD), which is taking place from 26-29 October, 2016 in Valencia, Spain.

View Analyst & Ambassador Comments
Go to original news
Oct 28,2016

Tandem Diabetes Care Announces Earlier Date for Q3 2016 Earnings Results and Conference Call

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, now plans to release its third quarter 2016 results after the markets close on Tuesday, November 1, 2016.

View Analyst & Ambassador Comments
Go to original news
Nov 10,2016

Intuity Medical raises $40M to bring blood glucose monitoring system Pogo to US market

Sunnyvale, California-based Intuity Medical, which makes diabetes management devices, has raised $40 million in a round led by PTV Healthcare Capital. New investors also included affiliates of Luther King Capital Management and existing investors Accuitive Medical Ventures, Investor Growth Capital, US Venture Partners, Venrock and Versant Ventures.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Nov 16,2016

Livongo's smart blood glucose meter now features downloadable updates

Mountain View, California-based Livongo Health, a chronic disease management company, has launched a new capability on its smart blood glucose meter. The device now employs one of the most basic – yet perhaps underrated – features of a smartphone: the ability to download over-the-air updates.

PRODUCT

#mobile app

#bgm

View Analyst & Ambassador Comments
Go to original news
Nov 17,2016

Mass Gen ResearchKit app GlucoSuccess shows impact of data insights on behavior in diabetes patients

As part of a talk at the Xconomy Forum in Boston today, Ausiello spoke about some lessons learned from GlucoSuccess, the Apple ResearchKit project launched by CATCH. Conversely, GlucoSuccess aims to help patients learn how their behaviors affect their health. Participants track activity duration and intensity, diet information, blood glucose measurements, body weight, and waist size, as well as glucose readings and diet information.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 17,2016

Eli Lilly offers app for people with diabetes using once-per-week medication Trulicity

Eli Lilly and Company has developed an app for people living with Type II diabetes who use Trulicity, the company’s once-per-week injectable diabetes medication that also works with a click-activated pen. The Trulicity app offers a few different features to aid those using the medication in their treatment: a virtual demo pen that mimics every feature, function and sound of the real Trulicity pen; weekly dosing reminders that users set for the day and time to take their medication, and the ability to instant message or call the Lilly Answer Center if they need any help with their medication.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES